TY - JOUR
KW - Vaccination
KW - Male
KW - Malawi
KW - leprosy
KW - Infant, Newborn
KW - Infant
KW - Humans
KW - Female
KW - Evaluation Studies as Topic
KW - Child, Preschool
KW - Child
KW - BCG Vaccine
KW - Adult
KW - Adolescent
AU - Fine PE
AU - Ponnighaus J M
AU - Maine N
AU - Clarkson J A
AU - Bliss L
AB - <p>The effectiveness of a BCG vaccination programme in protecting against leprosy was assessed by case-control and cohort analyses of data from the Lepra Evaluation Project in Karonga District, Northern Malawi. Results indicate that BCG provides at least 50% protection against leprosy in this population and that protection is independent of age, sex, schooling status, or location within the project area. Agreement between these findings and those from a controlled trial in Uganda indicates that BCG is sufficiently effective against leprosy in East and Central Africa to be considered an important element of leprosy control in that region.</p>
BT - Lancet
C1 - http://www.ncbi.nlm.nih.gov/pubmed/2875247?dopt=Abstract
DA - 1986 Aug 30
IS - 8505
J2 - Lancet
LA - eng
N2 - <p>The effectiveness of a BCG vaccination programme in protecting against leprosy was assessed by case-control and cohort analyses of data from the Lepra Evaluation Project in Karonga District, Northern Malawi. Results indicate that BCG provides at least 50% protection against leprosy in this population and that protection is independent of age, sex, schooling status, or location within the project area. Agreement between these findings and those from a controlled trial in Uganda indicates that BCG is sufficiently effective against leprosy in East and Central Africa to be considered an important element of leprosy control in that region.</p>
PY - 1986
SP - 499
EP - 502
T2 - Lancet
TI - Protective efficacy of BCG against leprosy in Northern Malawi.
UR - http://www.med.mcgill.ca/epidemiology/Hanley/bios601/CaseControlStudies/FineEtAlBCGleprosy.pdf
VL - 2
SN - 0140-6736
ER -